These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8542577)

  • 21. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
    Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
    Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.
    Chung SM; Kao J; Hyjek E; Chen YT
    Int J Oncol; 2007 Dec; 31(6):1351-5. PubMed ID: 17982662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma.
    Fein M
    Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229
    [No Abstract]   [Full Text] [Related]  

  • 27. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent microsatellite instability in primary small cell lung cancer.
    Merlo A; Mabry M; Gabrielson E; Vollmer R; Baylin SB; Sidransky D
    Cancer Res; 1994 Apr; 54(8):2098-101. PubMed ID: 8174113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of loss of heterozygosity on chromosome 17 during the progression to barrett's adenocarcinoma involves a unique combination of target sites in individual specimens.
    Dunn JR; Garde J; Dolan K; Gosney JR; Oates BC; Watson AJ; Fielding P; Field JK
    Clin Cancer Res; 2000 Oct; 6(10):4033-42. PubMed ID: 11051253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability analysis of primary human brain tumors.
    Zhu J; Guo SZ; Beggs AH; Maruyama T; Santarius T; Dashner K; Olsen N; Wu JK; Black P
    Oncogene; 1996 Apr; 12(7):1417-23. PubMed ID: 8622857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.
    Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH
    Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.
    Hardie LJ; Darnton SJ; Wallis YL; Chauhan A; Hainaut P; Wild CP; Casson AG
    Cancer Lett; 2005 Jan; 217(2):221-30. PubMed ID: 15617840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.
    Fang M; Lew E; Klein M; Sebo T; Su Y; Goyal R
    Am J Gastroenterol; 2004 Oct; 99(10):1887-94. PubMed ID: 15447746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triplet repeat instability correlates with dinucleotide instability in primary breast cancer.
    Pizzi C; Di Maio M; Daniele S; Mastranzo P; Spagnoletti I; Limite G; Pettinato G; Monticelli A; Cocozza S; Contegiacomo A
    Oncol Rep; 2007 Jan; 17(1):193-9. PubMed ID: 17143498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of D19S246 as a novel lung adenocarcinoma susceptibility locus by genome survey with 10-cM resolution microsatellite markers.
    Yanagitani N; Kohno T; Kim JG; Kunitoh H; Tamura T; Takei Y; Tsuchiya S; Saito R; Yokota J
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):366-71. PubMed ID: 12692112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic alterations in malignant transformation of Barrett's esophagus.
    Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H
    Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellite instability in germ cell tumors of the testis and ovary.
    Faulkner SW; Friedlander ML
    Gynecol Oncol; 2000 Oct; 79(1):38-43. PubMed ID: 11006028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
    von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
    Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.